Breakthrough: Chloroquine phosphate has shown apparent efficacy in treatment of COVID-19 associated pneumonia in clinical studies.Biosci Trends. 2020 Mar 16; 14(1):72-73.BT
Abstract
The coronavirus disease 2019 (COVID-19) virus is spreading rapidly, and scientists are endeavoring to discover drugs for its efficacious treatment in China. Chloroquine phosphate, an old drug for treatment of malaria, is shown to have apparent efficacy and acceptable safety against COVID-19 associated pneumonia in multicenter clinical trials conducted in China. The drug is recommended to be included in the next version of the Guidelines for the Prevention, Diagnosis, and Treatment of Pneumonia Caused by COVID-19 issued by the National Health Commission of the People's Republic of China for treatment of COVID-19 infection in larger populations in the future.
Links
MeSH
Pub Type(s)
Journal Article
Language
eng
PubMed ID
32074550
Citation
Gao, Jianjun, et al. "Breakthrough: Chloroquine Phosphate Has Shown Apparent Efficacy in Treatment of COVID-19 Associated Pneumonia in Clinical Studies." Bioscience Trends, vol. 14, no. 1, 2020, pp. 72-73.
Gao J, Tian Z, Yang X. Breakthrough: Chloroquine phosphate has shown apparent efficacy in treatment of COVID-19 associated pneumonia in clinical studies. Biosci Trends. 2020;14(1):72-73.
Gao, J., Tian, Z., & Yang, X. (2020). Breakthrough: Chloroquine phosphate has shown apparent efficacy in treatment of COVID-19 associated pneumonia in clinical studies. Bioscience Trends, 14(1), 72-73. https://doi.org/10.5582/bst.2020.01047
Gao J, Tian Z, Yang X. Breakthrough: Chloroquine Phosphate Has Shown Apparent Efficacy in Treatment of COVID-19 Associated Pneumonia in Clinical Studies. Biosci Trends. 2020 Mar 16;14(1):72-73. PubMed PMID: 32074550.
* Article titles in AMA citation format should be in sentence-case
TY - JOUR
T1 - Breakthrough: Chloroquine phosphate has shown apparent efficacy in treatment of COVID-19 associated pneumonia in clinical studies.
AU - Gao,Jianjun,
AU - Tian,Zhenxue,
AU - Yang,Xu,
Y1 - 2020/02/19/
PY - 2020/2/20/pubmed
PY - 2020/3/19/medline
PY - 2020/2/20/entrez
KW - 2019-nCoV
KW - COVID-19
KW - SARS-CoV-2
KW - chloroquine
KW - pneumonia
SP - 72
EP - 73
JF - Bioscience trends
JO - Biosci Trends
VL - 14
IS - 1
N2 - The coronavirus disease 2019 (COVID-19) virus is spreading rapidly, and scientists are endeavoring to discover drugs for its efficacious treatment in China. Chloroquine phosphate, an old drug for treatment of malaria, is shown to have apparent efficacy and acceptable safety against COVID-19 associated pneumonia in multicenter clinical trials conducted in China. The drug is recommended to be included in the next version of the Guidelines for the Prevention, Diagnosis, and Treatment of Pneumonia Caused by COVID-19 issued by the National Health Commission of the People's Republic of China for treatment of COVID-19 infection in larger populations in the future.
SN - 1881-7823
UR - https://www.unboundmedicine.com/medline/citation/32074550/full_citation
DB - PRIME
DP - Unbound Medicine
ER -
